Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 11:19 am Sale | 2022-12-30 | 13G | Enanta Pharmaceuticals, Inc. ENTA | The Vanguard Group | 1,522,189 7.320% | -103,720 (-6.38%) | Filing History |
| 2023-02-08 1:17 pm Purchase | 2022-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | STATE STREET CORP STT | 1,512,192 7.270% | 385,123 (+34.17%) | Filing History |
| 2023-02-06 09:06 am Purchase | 2022-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Farallon Capital Partners, L.P. | 1,550,000 7.500% | 1,550,000 (New Position) | Filing History |
| 2023-01-31 3:17 pm Purchase | 2022-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | BlackRock Inc. BLK | 3,753,075 18.000% | 281,660 (+8.11%) | Filing History |
| 2022-02-14 6:31 pm Unchanged | 2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Armistice Capital, LLC | 1,056,000 5.100% | 0 (Unchanged) | Filing History |
| 2022-02-14 6:18 pm Purchase | 2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | FIRST MANHATTAN CO. LLC. | 1,108,836 5.460% | 343,268 (+44.84%) | Filing History |
| 2022-02-14 5:14 pm Sale | 2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Armistice Capital, LLC | 1,056,000 5.100% | -300,000 (-22.12%) | Filing History |
| 2022-02-11 1:08 pm Sale | 2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | FARALLON CAPITAL MANAGEMENT LLC | 1,573,829 7.700% | -201,171 (-11.33%) | Filing History |
| 2022-02-11 11:11 am Sale | 2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | STATE STREET CORP STT | 1,127,069 5.550% | -46,171 (-3.94%) | Filing History |
| 2022-02-10 6:09 pm Sale | 2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Renaissance Technologies LLC | 714,400 3.480% | -319,500 (-30.90%) | Filing History |
| 2022-02-10 08:11 am Sale | 2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | The Vanguard Group | 1,625,909 8.000% | -174,670 (-9.70%) | Filing History |
| 2022-02-04 4:08 pm Sale | 2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Dworsky Alan J | 114,496 1.000% | -1,092,915 (-90.52%) | Filing History |
| 2022-01-28 1:54 pm Purchase | 2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | BlackRock Inc. BLK | 3,471,415 17.100% | 65,415 (+1.92%) | Filing History |
| 2021-12-17 4:31 pm Purchase | 2021-12-15 | 13D | Enanta Pharmaceuticals, Inc. ENTA | Luly Jay R. | 1,366,318 6.500% | 176,529 (+14.84%) | Filing History |
| 2021-02-16 5:05 pm Purchase | 2020-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Armistice Capital, LLC | 1,356,000 6.700% | 1,356,000 (New Position) | Filing History |
| 2021-02-16 12:23 pm Sale | 2020-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | T. Rowe Price Associates, Inc. | 961,445 4.700% | -434,890 (-31.15%) | Filing History |
| 2021-02-12 6:42 pm Purchase | 2020-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 8.800% | 25,000 (+1.43%) | Filing History |
| 2021-02-10 12:19 pm Purchase | 2020-09-18 | 13G | Enanta Pharmaceuticals, Inc. ENTA | Renaissance Technologies LLC | 1,033,900 5.130% | 1,033,900 (New Position) | Filing History |
| 2021-02-10 10:52 am Purchase | 2020-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | The Vanguard Group | 1,800,579 8.970% | 102,850 (+6.06%) | Filing History |
| 2021-02-09 12:33 pm Purchase | 2020-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | STATE STREET CORP STT | 1,173,240 5.840% | 1,173,240 (New Position) | Filing History |